Dr. Paner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1725 W Harrison Street
Chicago, IL 60612Phone+1 312-942-5978
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 2004 - 2007
Vilnius University Faculty of MedicineClass of 2003
Certifications & Licensure
IL State Medical License 2006 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2016 Dec 28
- A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma Start of enrollment: 2020 Feb 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 3 citationsImpact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phas...Katja Weisel, Meletios A Dimopoulos, Jesús San-Miguel, Agne Paner, Monika Engelhardt
Hemasphere. 2023-03-01 - 1 citationsNEW-ONSET CARDIAC AMYLOIDOSIS WHILE IN REMISSION FROM SYSTEMIC AL AMYLOIDOSIS.Abiodun Idowu, Lillian Tung, Catherine Chu, Jamario Skeete, Agne Paner
European Journal of Case Reports in Internal Medicine. 2023-01-01 - 5 citationsMelphalan flufenamide for relapsed/refractory multiple myeloma.Omar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, Agne Paner, Alessandra Larocca
Drugs of Today. 2022-08-01
Journal Articles
- The Present and Future Cardiovascular Medicine and Society the Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (Or Onco-Cardiology) and Call to ActionAgne Paner, Hena Patel, Timothy Kuzel, Parameswaran Venugopal, Tochi M Okwuosa, Nicole Prabhu, Kim A Williams, ScienceDirect
Abstracts/Posters
- The Burden of Relapsed/Refractory Multiple Myeloma: An Indirect Comparison of Health-Related Quality of Life Burden across Different Types of Advanced Cancers at Basel...Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Activity of Melflufen in Patients with Triple-Class Refractory Multiple Myeloma and Poor-Risk Features in an Updated Analysis of HORIZON (OP-106), a Phase 2 S...Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Impact of Elotuzumab Plus Pomalidomide and Dexamethasone on Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Enrolled in the ELOQUE...Agne Paner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
A Patient's Guide to Multiple MyelomaSeptember 25th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
